Circulating MicroRNAs in Newly Diagnosed Acute and Chronic Leukemias
نویسندگان
چکیده
Leukemia is a clonal disease caused by genetic-epigenetic aberrations and we investigated the profile of circulating 741 microRNAs (miRNA) in plasma of newly diagnosed acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML) patients compared to healthy individuals. MiRNAs are small non-coding RNA molecules and have critical roles in cell differentiation, proliferation, apoptosis. They regulate haematopoiesis in haematopoietic stem cells and committed progenitor cells, but they also play role in pathogenesis of acquired hematologic neoplasms. Recently, a growing body of evidence has implicated specific miRNAs in pathogenesis of leukemia and circulating miRNAs could serve as non-invasive biomarkers for detection of leukemia. Aim of this study was to identify miRNAs epigenetically regulated in acute and chronic leukemias. RNA was isolated using High Pure miRNA Isolation Kit (Roche) following manufacturer’s protocol. cDNA and preamplification protocols were obtained from isolated plasma miRNAs. The BioMarkTM 96.96 Dynamic Array (Fluidigm Corporation) for real-time qPCR was used to simultaneously quantite the expression of 741 miRNAs. Statistical analyses were performed using Biogazelle’s qbase PLUS 2.0 software. Among analyzed 741 miRNAs, mir-1290 and miR-548c-3p were down-regulated, mir-24-3p, miR-30b5p and miR-19a-3p were up-regulated in all leukemic patients comparing with control group (p< 0.05). However, in patients with ALL, mir-24-3p was significantly down-regulated and miR-548c-3p was significantly up-regulated compared to healthy subjects (p< 0.05). Our study is the first study showing the higher expression levels of miR-548c-3p in ALL. We conclude that miR-24-3p and miR-548c-3p can be used as potential biomarkers for detecting ALL.
منابع مشابه
The role of microRNA in acute/chronic, myeloid/lymphocytic leukemia
MicroRNAs are small, non-coding sequences that regulate gene expression by inducing degradation or translational inhibition of target mRNAs. These molecules control many intracellular physiological and pathological processes.Abnormal expression of these moleculs has been described in different cancers including hematopoietic cancers. According to the type of cancer and the stage, miRNA’s expres...
متن کاملClinical, Morphological and Immunophenotypical Findings in Acute Leukemia: A Study from a Tertiary Care Hospital
Background: Acute leukemias comprise a heterogeneous group of diseases characterized by rapid and uncontrolled clonal expansion of progenitor cells of the hematopoietic system. Immunophenotyping helps subclassify acute leukemias into subgroups with prognostic implications. Materials and Methods: This descriptive observational cross-sectional study was performed on 80 newly diagnosed cases of a...
متن کاملMicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders
Common blood disorders include hematopoietic cell malignancies or leukemias and plasma cell dyscrasia, all of which have associated microRNA abnormalities. In this paper, we discuss several leukemias including acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL) and identify altered microRNAs and their targets. Immune disorders with altered blood levels of antibodies include auto...
متن کاملIdentification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The disease is characterized by various cytogenetic and molecular abnormalities with distinct prognoses and gene expression profiles. Emerging evidence has suggested that circulating microRNAs (miRNAs) could serve as noninvasive biomarkers for cancer detection; however, little is known about circulating miRNA profiles in ...
متن کاملLeukemia: A Transition From Basic Science to Clinical Practice.
The term "leukemia" actually refers to a family of blood cancers, each having a distinct pattern of symptoms and cytology and each differing in age of onset, prognosis, and therapeutic options. The acute leukemias -acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL) -have been recognized for their rapid clinical progression when untreated and are diagnosed by the identificat...
متن کامل